Now Playing

Diet Drug Qnexa Gets Thumbs-Up From FDA Panel

In a reversal, a panel of experts is advising the Food and Drug Administration to approve Qnexa, a weight-loss pill, that was rejected in 2010. The potential benefits for overweight people exceed the risks, such as birth defects and increased heart rates, the panel determined.

Trouble listening? See our technical support page.